StockData
Evofem Biosciences, Inc. logo

Evofem Biosciences, Inc. (EVFM) stock

EVFMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.01−0.00 (-10.00%)

Close on Oct 19, 2026Market cap $865.23KP/E –Yield –

Evofem Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Evofem Biosciences's total debt was $362.00K at Jun 30, 2026. For fiscal 2025 it was $147.00K, up 8.9% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$147.00K+8.9%
FY2024Dec 31, 2024$135.00K-98.6%
FY2015Dec 31, 2015$9.96M+2.3%
FY2014Dec 31, 2014$9.74M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$362.00K+168.1%
Q4 FY2025Dec 31, 2025$147.00K-45.1%
Q3 FY2025Sep 30, 2025$291.00K-26.7%
Q2 FY2025Jun 30, 2025$383.00K-90.4%
Q4 FY2024Dec 31, 2024$135.00K–
Q3 FY2024Sep 30, 2024$268.00K–
Q2 FY2024Jun 30, 2024$397.00K–
Q2 FY2016Jun 30, 2016$4.00M–

More Evofem Biosciences figures

See a number that looks wrong?